-
Mashup Score: 5
“A key piece of the guideline is that we need to offer radiation at a PSA of 0.5 ng/mL or lower and maybe even, for some patients, a PSA lower than 0.2 ng/mL,” says Todd M. Morgan, MD.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 3Trial begins of NUV-1511 in solid tumors, including mCRPC - 2 month(s) ago
Overall, the phase 1/2 trial is designed to explore the safety, tolerability, pharmacokinetics, and preliminary clinical activity of NUV-1511 in patients with advanced solid tumors.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 3The Evolution of Imaging Techniques in Prostate Cancer - 2 month(s) ago
A panel of expert oncologists in prostate cancer give an overview of the evolution of imaging techniques used for patients with prostate cancer.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 2
“The test is designed to non-invasively identify the presence of aggressive cancer in men already diagnosed with prostate cancer who are on or are considering starting active surveillance,” says Kirk J. Wojno, MD.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
Dr. Todd M. Morgan discusses the inclusion of PSMA-PET imaging in the guideline on salvage therapy for prostate cancer. @wandering_gu @UMichUrology #pcsm #urology #oncology Watch now: https://t.co/0QkgMq8Yxh